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ABSTRACT 
Objective: This study was designed to evaluate the effect of Ayurvedic pharmaceutical procedures Shodhana and Marana on the chemical 
composition of the raw material.  
Methods: Iron and four iron-containing minerals were subjected to Shodhana and Marana. For Shodhana, Loha (Iron), Suvarnamakshika (Copper 
pyrite) and Mandura (iron slag,) were repeatedly quenched sequentially in sesamin oil, buttermilk, cow’s urine, natural vinegar and herbal 
decoctions. Kasisa (green vitriol) was grinded in the juice of Eclipta Alba. For Marana, these materials were first grinded in prescribed liquids and 
then incinerated in closed earthenware caskets in measured pits. Powdered Gairika (red ochre) was roasted in Cow’s ghee for its Shodhana. Samples 
of Loha (iron)-L1, Samanya Shodhita Loha–L2, Vishesha Shodhita Loha–L3, Loha bahsma-L4, Mandura (iron slag)–M1, Shodhita Mandura–M2, 
Mandura bahsma–M3, Suvarnamakshika (copper pyrite)-S1, Shodhita Suvarnamakshika-S2, Suvarnamakshika bhasma-S3, Kasisa (green vitriol)-K1, 
Shodhita Kasisa-K2, Kasisa bahsma–K3, Gairika (red ochre)-G1 and Shodhita gairika-G2; were studied using XRF and XRD techniques.  
Results: XRD findings suggested that the Chemical nature, elemental composition and Crystaline lattice structure of each substance were altered 
after extensive processings. XRF studies confirmed the multi-elemental nature of the final products. Reduction in particle size and other 
morphological changes were observed in intermediate and finished products during each procedure.  
Conclusion: The study indicates that the composition of material is altered as a result of Ayurvedic pharmaceutical processing, ’Shodhana and Marana. 
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INTRODUCTION 
A branch of Ayurvedic medicine that principally deals with metallic 
and mineral drug preparations is known as Rasa Shastra. The drugs of 
Metallic and mineral origin are processed with an objective to make 
them edible, therapeutically effective and completely safe in 
therapeutic doses. Generally, a raw metallic or mineral drug substance 
undergoes through the following pharmaceutical procedures.  
The raw material fulfilling the required criteria of selection for its 
use in drug preparation is usually collected from the market. The 
collected raw material is first made suitable for further processing 
like preparation of thin metal sheets or grinding the raw material to 
produce a powder of suitable particle size. The thin metal sheets or 
the metal powder as the case may be, are subjected to a 
pharmaceutical procedure named Shodhana [1] in terms of 
Ayurveda. The literal meaning of Shodhana is purification. But 
translation of the term Shodhana as purification produces a 
misperception about the objective and the real effect of the 
Shodhana procedure. Hence such translation should never be used. 
Purification in the process of Shodhana is restricted only to physical 
purification. It nowhere implies or achieves chemical purity of the 
material being processed. In addition to physical purification, the 
procedure softens the processed material to some extent and makes 
it ready for further processing. In some cases, particularly in case of 
some minerals which are soft in consistency like red ochre used in 
the present study, the softening of the material is sufficient to put 
the material directly to therapeutic use. In such cases the material 
also becomes safe for internal use in therapeutic doses following 
Shodhana. Metals are usually subjected to two types of Shodhana: 
Samanya (common for all metals) and Vishesh (specific to a metal to 
be used with a specific therapeutic objective). All metals and 
minerals which are hard in consistency need to undergo one more 
pharmaceutical procedure named as Marana [2] following 
Shodhana.  
The pharmaceutical process of Shodhana includes procedures like 
heating the material to red heat and then quenching it in prescribed 
liquids till the material under process achieves the required quality. 
The pharmaceutical process of Marana to be followed after 
Shodhana includes incineration of the material obtained as an end 
product of the process of Shodhana. The material obtained from 
Shodhana is first wet ground with prescribed medicinal substances 
either liquid or solid or both, depending on the prescribed method. 
The grinding is continued till the material is converted into a dough. 
The dough so produced is used to prepare small cakes of suitable 
size. The cakes so produced are dried and put in a closed circular 
earthenware container known as casket (Sharava Samputa in terms 
of Ayurveda) and then subjected to incineration in a measured pit 
using dried cow dung cakes as fuel. The process of incineration is 
repeated till a product of desired quality is obtained. The product 
obtained after completion of incineration is known as Bhasma. Both 
these processes named Shodhana and Marana bring about 
significant change in the constitution of the processed material. 
Naredran N. et al. (2012) have shown the reducing effect of Gallic 
acid from Horse gram on Loha Bhasma during Marana [3]. In the 
present study the metal Loha (metal Iron) and minerals Gairika (red 
ochre), Kasisa (ferrous sulphate), Suvarnamakshika(Copper pyrite) 
and Mandur (iron slag, ferric oxide) were subjected to their 
respective Shodhana and Marana to obtain their therapeutically 
useful drug forms named as Bhasma. These Bhasmas and their 
intermediates obtained as end products following their Shodhana 
and Marana were subjected to XRD and XRF analysis to study the 
effect of these procedures on the constitution of the processed raw 
metals and minerals.  
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MATERIALS AND METHODS 
Collection of raw materials 
The raw material i.e. Loha (metal Iron), Gairika (red 
ochre), Kasisa(green vitriol: ferrous sulfate), Suvarnamakshika 
(Copper pyrite), and Mandura (iron slag: ferric oxide) fulfilling the 
expected quality as described in the classical texts [4] were collected 
from the local market.  
The raw materials so collected were subjected to their 
respective Shodhana and Marana procedures. The end products 
obtained following completion of both the procedures were Loha 
Bhasma, Mandura Bhasma, Suvarnamakshika Bhasma, Kasisa 
Bhasma, and Shuddha Swarna Gairika.  
Pharmaceutical processing 
Loha (metal Iron) was subjected to the following pharmaceutical 
processing to obtain Loha Bhasma.  
Shodhana and marana of loha 
Loha Bhasma preparation includes the following steps. 
Loha samanya shodhana  
Moderately fine powder of Loha was heated till it gets red hot and 
quenched three times each into Sesame oil, buttermilk, kanjika (sour 
rice gruel), cow’s urine, and decoction of Kulattha (horse gram), 
respectively [5]. 
Loha vishesh shodhana 
After Following Samanya Shodhana, Vishesh Shodhana was 
performed. Loha choorna was heated till it gets got red hot and 
quenched seven times in the decoction of Triphala prepared in 
Gomutra (cow’s urine). By this method, Shuddha Loha Choorna was 
obtained [6]. 
Loha marana 
After Following Loha Shodhana, Shuddha Loha was subjected to 
Loha Marana. It was done in three steps. 
Loha bhanupaka 
Shuddha Loha choorna was soaked in specially prepared Triphala 
decoction to make it produce its slurry. The mixture was kept in an 
open earthen plate. This plate was exposed to blazing sunlight till all 
the liquid got evaporated. The process was repeated 7 times [7].  
Loha sthalipaka 
Loha choorna processed in Bhanupaka was washed with water. It 
was then mixed in specially prepared Triphala decoction (q. s.) to 
produce a slurry. The mixture was then subjected to heating on a 
high flame. This was continued till all the moisture got evaporated. 
The process is known as Loha Sthalipaka [8]. 
Loha putpaka 
Loha Choorna was obtained as an end product of Bhaupaka followed 
by Sthalipaka, was washed with water and then ground well with 
specially prepared Triphala decoction to produce a soft dough. Thin 
flat pellets from this dough were prepared and dried. They were 
arranged and placed in a closed circular earthenware container 
known as Sharava samputa (casket) and then subjected to 
incineration in a measured pit named Gajaputa, using dried cow 
dung cakes as fuel. The process was repeated till the desired 
quality Bhasma was obtained [9]. 
Mandura (iron slag) was subjected to the following procedures 
to obtain mandura bhasma 
Shodhana of mandura 
Raw Mandura (iron slag) lumps were procured from the market. 
They were heated till they got red hot. Thereafter, n they were 
quenched in the decoction of Triphala 21 times. This decoction was 
prepared by boiling Triphala in cow urine instead of water. This 
process yielded small fragile pieces of Shuddha Mandura [10]. 
Marana of mandura 
Shuddha Mandura obtained as an end product of the 
Shodhana process was subjected to wet grinding with Aloe 
juice (Aloe barbadensis) to produce a soft dough. Thin flat pallets 
from this dough were prepared and dried. They were arranged and 
placed in a closed circular earthenware container known as Sharava 
samputa (casket) and then subjected to incineration in a measured 
pit named Gajaputa, using dried cow dung cakes as fuel. The process 
was repeated till the desired quality Bhasma was obtained [11]. 
Suvarnamakshika (copper pyrite) was subjected to the 
following procedures to obtain Suvarnamakshika Bhasma.  
Preparation of Suvarna makshik Bhasma includes the following steps. 
Shodhana of suvarna makshika 
Raw Suvarnamakshika was procured directly from Khetri Mines 
Rajsthan.  
The lumps were subjected to the Shodhana process by quenching 
them in Triphala decoction 7 times. This process yielded Shuddha 
Suvarnamakshika in the form of brittle pieces [12]. 
Marana of suvarna makshika 
Shuddha suvarmnamakshika was mixed with castor oil (q. s.) to produce 
a slurry. This slurry was subjected to heating in an open iron pan till all 
the oil part was evaporated. Oil catches fire during the process.  
The material obtained as an end product of the above-mentioned 
procedure was subjected to wet grinding with lemon J juice to 
produce a soft dough. Thin flat pallets from this dough were 
prepared and dried. They were arranged and placed in a closed 
circular earthenware container known as Sharava samputa (casket) 
and then subjected to incineration in a measured pit 
named Gajaputa, using dried cow dung cakes as fuel. The process 
was repeated till the desired quality Bhasma was obtained [13]. 
Kasisa(green vitriol: ferrous sulfate) was subjected to the 
following procedures to obtain Kasisa a Bhasma 
Preparation of Kasisa Bhasma includes the following steps. 
Kasisa shodhana 
Kasisa Choorna was procured from the local market. It was subjected 
to wet grinding with a sufficient quantity of juice 
of Bhringraj (Eclipta Alba) in a quantity sufficient to soak and 
immerse the Kasisa powder in it completely. The mixture was wet 
ground firmly till all the powder of Kasisa gets dried by grinding. 
This process was repeated three times consecutively. Thus Shuddha 
Kasisa was obtained as an end product of this grinding in the form of 
very fine powder [14]. 
Kasisa marana  
Shuddha Kasisa obtained as an end product of the Shodhana process 
was wet ground with a sufficient quantity of lemon juice to produce 
a soft dough. Thin flat pallets from this dough were prepared and 
dried. They were arranged and placed in a closed circular 
earthenware container known as Sharava samputa (casket) and then 
subjected to incineration in a measured pit named Gajaputa, using 
dried cow dung cakes as fuel. The process was repeated till a desired 
quality of Bhasma was obtained [15].  
Gairika (red ochre) was subjected to the following procedures 
to obtain Shuddha Gairika  
This compound is not used in Bhasma form. Gairika is used 
after Shodhana only. Gairika powder was mixed with Cows ghee 
taken in 1/8th of its measure. Further, it was roasted on mild heat, 
till ghee mixed in Gairika powder disappears by frying and a free-
flowing powder of Gairika is obtained. This processed Gairika is used 
as medicine. This is called Shuddha Gairika [16]. 
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Table 1: Schematic representation of processing’s of Iron metal and other Iron containing drugs 
Processing 
The Raw Loha---Samanya Shodhana-----Vishesh Shodhana-----Bhanupaka---Sthalipaka------Putapaka-----Loha Bhasma. 
Raw Mandura------Shodhana of Mandura----Marana of Mandura---Mandura Bhasma  
Raw Suvarnamakshika------Shodhana of Suvarnamakshika----Marana of Suvarnamakshika----Suvarnamakshika Bhasma  
Raw Kasisa------Shodhana of Kasisa-------Marana of Kasisa-----Kasisa Bhasma. 
Raw Gairika-------Shodhana of Gairika----Shuddha Swarna Gairika.  
 
Table 2: Medium used for Shodhana and Marana procedures of each drug, all the materials were tested for their authenticity, following 
Indian standards and in-house standards 
Drug  Drugs used for 
Shodhana  
Preparation of medium  Drugs used 
for Marana 




Sesame oil, Procured from local market  Bhanupaka 
Triphala 
Decoction  
Course powder of Triphala weighing 
equal to the quantity of Lohaand passing 
through sieve no 44 was mixed with 
double parts of water, boiled, and reduced 
to 1/4th of the original quantity. 
 Buttermilk, 
 
Cow’s milk inoculated with curd. Next day curd was 
mixed with water (2:1) and churned. Butter was 




Course powder of Triphala weighing 
triple to the quantity of Loha a and 
passed in g through sieve no 44 was 
mixed with double parts of water, boiled, 
and reduced to 1/4th of the original 
quantity. 
 Cow’s Urine 
 
Procured from local source. Putpaka 
Triphala 
Decoction 
Course powder of Triphala passed ing 
through sieve no 44, was mixed with 16 
parts of water, boiled, and reduced to 
1/8th of the original quantity. 
 Kanji Parboiled Precooked rice was cooked and mixed with 
3 parts of water. The mixture was kept aside for 7 d. 
It was filtered after that and the filtrate taken for the 
process.  
  
 Decoction of 
Horse Gram 
 Horse gram (Dolichos biflorus) seeds were soaked 
overnight in water. They were cooked in 16 times of 
water till the water was reduced to 1/8th of the 







Course powder of Triphala passing through sieve no 
44 was mixed with 16 parts of water, boiled, and 




Course powder of Triphala passing through sieve no 
44 was mixed with 16 parts of cow’s urine, boiled, 
and reduced to 1/8th of the original quantity. 
Aloe Vera 
Juice  
Juice expressed from Aloe Vera leaves.  
Kasisa Juice extract of 
Eclipta Alba  
Juice is expressed from fresh Eclipta Alba leaves.  Lemon Juice  Expressed juice from Lemon (Citrus 





Course powder of Triphala passing through sieve no 
44 was mixed with 16 parts of water, boiled, and 
reduced to 1/8th of the original quantity. 
Castor oil  Procured from local market.  
   Lemon Juice  Expressed juice from Lemon (Citrus 
Acida Fruits 
Gairika  Cow’s ghee  Procured from the Market  - - 
After such an extensive procedure of Shodhana and Marana the following samples were withdrawn for the study.  
 
Table 3: The samples collected for XRD and XRF studies at different stages of pharmaceutical processing 
Name of the material  Samples taken  Description  Analysis Performed 
Iron  L1 Raw Loha  XRD 
 L2 After Samanya Shodhana XRD 
 L3 After Vishesh Shodhana  XRD 
 L4 Bhasma (Calx) XRD and XRF  
Gairika  G1 Raw Gairika  XRD 
 G2 Shuddha Gairika  XRDand XRF 
Suvarna makshik  S1 Raw Suvarna makshika XRD  
 S2 Shuddha Suvarna makshika XRD 
 S3 Bhasma of Suvarna makshika XRDand XRF 
Kasisa  K1 Raw Kasisa  XRD  
 K2 Shuddha Kasisa  XRD 
 K3 Bhasma of Kasisa  XRDand XRF 
Mandura M1 Raw Mandura  XRD  
 M2 Shuddha Mandura XRD 
 M3 Bhasma of Mandura  XRDand XRF 
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Description of XRD studies–Powder X-ray diffraction spectra were 
recorded at 298K on a Bruker D8-Ray diffractometer, with a 0.2 step 
size at 0.0a2 theta/min scanning speed, 40 kV voltage, 40mA current 
between scanning angles 5 to 90 (2 thetas).  
Description of XRF studies–X-Ray fluorescence was done at Varsha 
Bullion Lab in Mumbai. 
RESULTS 
The results were recorded as follows. 
  
- 
Fig. 1: XRD analysis of raw Gairika and shuddha Gairika revealed interesting findings 
 
2-Theta-scale 
Gairika-File: G1. raw-Type: 2Th/Th locked-Start: 5.000°-End: 
80.005°-Step: 0.021°-Step time: 17.7 s-Temp.: 25 °C (Room)-Time 
Started: 10 s-Anode: Cu-WL1: Operations: Y Scale Add 792 | Smooth 
0.150 | Background 1.000,1.000 | Import 
G2-File: G2. raw-Type: 2Th/Th locked-Start: 5.000°-End: 80.005°-
Step: 0.021°-Step time: 17.7 s-Temp.: 25 °C (Room)-Time Started: 9 
s-Anode: Cu-WL 1: 1.540perations: Smooth 0.150 | Background 
1.000,1.000 | Import 
G1 and G2 have their X-ray characteristic peaks at 2-theta values 
of 12, 21, 25, 33, 36, 49, and 54, which correspond to the lattice 
indices of 111, 220, 222, 104, 110, 024, and 116, respectively. The 
crystallinity of the compounds based on XRD analysis shows 
similarity with Iron Tin Oxide (01-088-0434 (N)) with 
Rhombohedral lattice. There is no remarkable change in 
crystallinity of Gairikaa due to processing from G1 to G2. The 
crystalline phase remains Rhombohedral. This may be because of 
the roasting of Gairika with ghee. The process doesn’t involve 
intense heat. Hence the crystalline phase didn’t change. Percentage 
crystallinity is decreased in G2 because of heat treatment. The XRF 
studies revealed that Shuddha Gairika contains 35.8% of ferric 
oxide, 34.3% of silica, Al2O3 in 28.4%. Also, there are some trace 
elements found in G2. 
 
 
Fig. 2: The XRD analysis findings in case of Mandura are as follow 
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2-Theta–Scale Mandur-File: M1. raw-Type: 2Th/Th locked-Start: 
5.000 °-End: 90.023°-Step: 0.100°-Step time: 35.4 s-Temp.: 25 °C 
(Room)-Time Started: 12 s-Anode: Cu-WL1 Operations: Y Scale Add 
125 | Smooth 0.150 | Background 1.000,1.000 | Import 
M2-File: M2. raw-Type: 2Th/Th locked-Start: 5.000°-End: 90.023°-
Step: 0.100°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 10 
s-Anode: Cu-WL 1: 1.5Operations: Y Scale Add 292| Y Scale Add 708 
| Smooth 0.150 | Background 1.000,1.000 | Import 
M3-File: M3. raw-Type: 2Th/Th locked-Start: 5.000°-End: 90.039°-
Step: 0.080°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 12 
s-Anode: Cu-WL 1: 1.5 Operations: Y Scale Add-1000 | Y Scale Add 
1000 | Y Scale Add 1000 | Y Scale Add 1000 | Smooth 0.150 | 
Background 1.000,1.000 | Import \ 
The XRD analysis of Mandura reveals the structure of the compound as 
Orthorhombic with major characteristic peaks matching with Iron 
Silicate-Fe2SiO4 (M1 and M2). Major XRD peaks for Mandura are 
observed at 25, 32, 35, 36, and 52 two-theta values correspond to 111, 
130, 131, 112, and 222 respectively. The crystalline phase change was 
observed from Orthorhombic (M1 and M2) to Rhombohedral (M3). 
The crystalline phase change is due to intense treatment of heat and 
trituration. Even the peaks are found more intense in M3 than M1 and 
M2. The major peaks observed for M2 are at 24, 33, 36, 41, 49, and 54 
two-theta values corresponding to hkl values of 012, 104, 110, 113, 
024, and 211 respectively. The amount of crystallinity also changes 
from M1 to M3. The XRF studies of Mandura Bhasma showed the 
presence of 58.3 % of ferric oxide, 19.6% of silica, 11.3 % of Alumina, 
and the rest of the other elements like K, Ca, S, P, etc. 
  
 
Fig. 3: Results of XRD studies of Kasisa were as follows 
 
Kasisa-File: K_1. raw-Type: 2Th/Th locked-Start: 5.000°-End: 
80.005°-Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time 
Started: 14 s-Anode: Cu-WL1:Operations: Y Scale Add 375 | Y Scale 
Add 542 | Smooth 0.150 | Smooth 0.150 | Smooth 0.150 | Smooth 
0.150 | Background 1.000,1.000 | Import 
K2-File: K2. raw-Type: 2Th/Th locked-Start: 10.000°-End: 89.995°-
Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 9 
s-Anode: Cu-WL1: 1.5 Operations: Y Scale Add-42 | Y Scale Add 417 | 
Smooth 0.150 | Smooth 0.150 | Smooth 0.150 | Smooth 0.150 | 
Smooth 0.150 | Smooth 0.150 | S 
K3-File: K3. raw-Type: 2Th/Th locked-Start: 10.000°-End: 89.995°-
Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 14 
s-Anode: Cu-WL1: 1. Operations: Smooth 0.150 | Smooth 0.150 | 
Smooth 0.150 | Smooth 0.150 | Smooth 0.150 | Smooth 0.150 | 
Smooth 0.150 | Smooth 0.150 | Smooth 
The Peaks of XRD are matching with Iron Sulphate Hydrate (K1), Iron 
hydroxide sulfate (K2), and Iron tin oxide (K3). The crystalline phase 
change was observed from Monoclinic (K1) to Orthorhombic (K2) to 
Rhombohaxes (K3). The crystalline phase change is due to the intense 
treatment of heat and grinding. Even the peaks are found more intense 
in K3 than K1 and K2. Peaks at the 2-theta value of 17, 25, 28, and 31 
correspond to K2 with indices values of 101, 002, 102, and 112, 
respectively. K3 has major XRD characteristic peaks at 24, 33, 36, 41, 50, 
and 54 with indices of 012, 104, 110, 113, 024, and 116, respectively. The 
amount of crystallinity also changes from K1 to K3. The XRF studies 
showed the presence of 93.2 % of ferric oxide, 1.22% of silica, and the 
rest of the other elements like K, Ca, S in Kasisa Bhasma. 
  
 
Fig. 4: Results of XRD studies of suvarna makshik were as follows 
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2-Theta–scale 
SM-File: S1. raw-Type: 2Th/Th locked-Start: 5.000 °-End: 80.005°-
Step: 0.021°-Step time: 17.7 s-Temp.: 25 °C (Room)-Time Started: 9 
s-Anode: Cu-WL 1: 1.54Operations: Scale Add 500 | Y Scale Add 792 | 
Smooth 0.150 | Smooth 0.150 | Background 1.000,1.000 | Import 
S2-File: S2. raw-Type: 2Th/Th locked-Start: 5.000°-End: 90.023°-
Step: 0.100°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 10 
s-Anode: Cu-WL 1: 1.5Operations: Y Scale Add 917 | Smooth 0.150 | 
Smooth 0.150 | Background 1.000,1.000 | Import 
S3-File: S3. raw-Type: 2Th/Th locked-Start: 5.000°-End: 80.005°-
Step: 0.021°-Step time: 17.7 s-Temp.: 25 °C (Room)-Time Started: 9 
s-Anode: Cu-WL 1: 1.54 Operations: Smooth 0.150 | Smooth 0.150 | 
Background 1.000,1.000 | Import 
The XRD studies on raw, intermediate Swarnamkashika and 
Swarnamkashika Bhasma revealed the following results. XRD 
analysis of Swarnamkashika Bhasma (S3) reveals the major XRD 
peaks at 2-theta values of 18, 39, 35.5, 43, 57, and 63, which are 
matching accurately with the XRD pattern of copper iron oxide 
having indices at 111, 220, 311, 400, 511, and 440 for respective 
peaks. The peaks in XRD are matching with the Copper iron sulfide 
(S1), Copper manganese oxide (S2), and copper-iron oxide (S3). The 
crystalline phase change is observed as Orthrorhombic (S1) to Cubic 
(S2) and Cubic (S3).  
(Peaks for S1-20, 25.5, 27, 30, and 49 corresponds to 121, 101, 130, 
012, and 330, respectively.) 
(Peaks for S2 at 19, 31, 36, 46, 54, 58 and 64 corresponds to 
111,220, 311, 331, 442, 511, and 440) 
S3 is more crystalline compared to S2 and S1. The peaks are also 
sharp and intense. The XRF studies of Swarnamakshika Bhasma (S3), 
showed the presence of ferric oxide 29.9%, Sio2 46.3%, CuO 3.6%. 
The rest of the elements are present in a minor amount. 
 
 
Fig. 5: Results of XRD studies of Loha were as follows 
 
2-Theta-scale 
L1-File: L1. raw-Type: 2Th/Th locked-Start: 5.000°-End: 90.023°-
Step: 0.100°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 12 
s-Anode: Cu-WL 1: 1.54Operations: Y Scale Add 1000 | Y Scale Add 
1000 | Y Scale Add 1000 | Y Scale Add 1000 | Smooth 0.150 | 
Background 1.000,1.000 | Import 
L2-File: L2. raw-Type: 2Th/Th locked-Start: 10.000°-End: 89.995°-
Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 15 
s-Anode: Cu-WL1: 1.5Operations: Y Scale Add 458 | Y Scale Add 
1000 | Y Scale Add 1000 | Y Scale Add 1000 | Smooth 0.150 | 
Background 1.000,1.000 | Import 
L3-File: L3. raw-Type: 2Th/Th locked-Start: 10.000°-End: 89.995°-
Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 8 s-
Anode: Cu-WL1: 1.54Operations: Y Scale Add 1000 | Y Scale Add 1000 
| Y Scale Add 1000 | Smooth 0.150 | Background 1.000,1.000 | Import 
L4-File: L4. raw-Type: 2Th/Th locked-Start: 10.000°-End: 89.995°-
Step: 0.021°-Step time: 35.4 s-Temp.: 25 °C (Room)-Time Started: 0 
s-Anode: Cu-WL1: 1.54Operations: Smooth 0.150 | Background 
1.000,1.000 | Import 
Peaks in XRD analysis of all the four samples of Loha a were 
matching with Iron oxide right from Ashuddha Loha (L1), Samanya 
shodhit Loha (L2), Vishesh Shodhit Loha (L3), and Loha 
a Bhasma (L4). L4 has major XRD characteristic peaks at two theta 
angles of 30, 35, 43, 54, 57, and 63 which corresponds to 220, 311, 
400, 422, 511, and 440 indices respectively. L1, L2, and L3 have 
peaks at 31, 36, 44, 57, and 63 which corresponds to the iron oxide 
XRD pattern with indices at 220, 313, 400, 422, and 440. The 
difference was observed in the crystalline phase, which has changed 
from tetragonal (L1, L2, and L3) to Cubic structure (L4). The peaks 
are intense, sharp, and well defined in the XRD pattern of Loha 
a Bhasma. The intense peaks represent the highly crystalline form of 
the compound (L4); the heat treatment has adversely affected the 
crystallinity of the compound and changes it to cubic form. 
According to the XRF studies of Loha a Bhasma, it contains Fe2O3 
88%, Silica in 4.87%, and other elements such as K, Ca, P, AL, O, Ma, 
Zn, in trace amounts.  
DISCUSSION 
The XRD and XRF studies of 5 iron-containing drugs and their 
intermediates revealed interesting findings. These procedures 
brought a change in the elemental composition of medicinal raw 
material. The extensive heat treatments and other procedures on 
raw materials of Ayurvedic drugs change their structure and 
composition. The XRD data has revealed that some elements were 
removed, changed, or minimized after Shodhana and Marana 
procedures. This clearly shows the effectiveness of the adopted 
pharmaceutical procedures.  
In some samples in the above study, although no constitutional 
change is observed in the processed material, the brittleness of the 
material was observed to increase notably at the end of Shodhana. 
An increase in brittleness is known to facilitate further processing 
of Marana in such cases.  
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It is believed that the use of different medicinal liquids in the form of 
decoctions and expressed juices for grinding the raw materials to 
facilitate pharmaceutical processing like Shodhana and Marana are 
responsible for the therapeutic action of the end 
product Bhasma. These Bhasmas are used with different adjuvants in 
medical practice by the Ayurvedic practitioners to derive different 
therapeutic effects. These processes make this one single end 
product able to be used in various conditions with different 
adjuvants. They make them a broad spectrum Ayurvedic drug.  
XRD data has revealed that there is a change in the arrangements of 
the lattice structure of crystals. The amount of crystallinity has 
increased. This is important because the bioavailability of the drug 
in the body depends upon its structure. In some cases (L4 and S3), 
major changes in crystal structure have been observed. This could 
be the result of the co-crystallization of compounds. Co-crystals are 
multicomponent crystalline solids that can alter the Physico-
chemical properties of solids. They can increase or decrease the 
solubility of the drug compounds depending on the interaction 
between the solids. The observed change in XRD pattern for L4 and 
S3 possibly be a result of crystallization between phenolic 
compounds that can further be evaluated in a separate study. 
Sharp intense peaks and clear smooth graphs in XRD of the final 
products compared to raw material and intermediates denote the 
uniform homogeneous phase of the final drug. This is achieved with 
the help of extensive Shodhana and Marana procedures. These 
treatments turn raw material into the final drug of acceptable 
quality and efficacy.  
A common pattern regarding the change in the chemical constitution 
of all 5 drugs is observed in this study. This pattern indicates the 
transformation of all raw materials into their oxides. All the 5 iron-
containing raw materials were observed as being transformed into 
iron oxide following Marana. The oxides are known to be more 
acceptable in the body. Singh. N et al. have observed similar findings 
in their study on Loha Bhasma. According to them the ultimate phase 
of Loha Bhasma was observed as Iron oxide only [17]. 
After the cascade of these intense procedures, particle size of all 
these bhasma was reduced significantly. PAvani et al. have 
confirmed the particle size of Loha bhasma to be 28.7 nm [18]. 
Some part of every bhasma is in nanodomain also. There is a trend of 
preparation of metal nanoparticles with green synthesis method. 
The herbal juices of various plants are used for preparation of 
nanoparticles by green synthesis. Some of these plants are 
Ayurvedic herbs. P. Karan et al. have described the green 
biosynthesis of Magnetic Iron oxide Nanoparticles of Vitex Nigundo 
aqueous extract. They have stated that such biosynthetically 
prepared iron oxide nanoparticles can be a good source of 
alternative therapy for human diseases [19]. 
Patil Y et al. have recently reported the antimicrobial activity of 
magnetic iron nanoparticles. These magnetic iron nanoparticles 
were prepared by green synthesis process using leaf extract of 
medicinal plant Tridax Procumbens. These magnetic iron 
nanoparticles exhibited good antibacterial activity against gram–
negative (E. Coli) bacteria [20]. 
This is clear that these finally prepared Bhasmas have some 
nanomaterial part in them. In our opinion these bhasmas can exibit 
superior pharmacological activity over the synthetically prepared 
nanoparticles. The resion reason is that they have gone throuogh 
extensive processes during their preparation. Hence their 
bioavailablity and bioassimilable nature could be superior to these 
synthetically prepared nanoparticles. This point needs a separate 
study for its evaluation. Further, these bhasmas are in clinical use 
since ages hence using these bhasmas will save lots of energy and 
time of various preclinical studies as their safety is already well 
explored in several different studies.  
Although XRD studies revealed the major elemental phase 
composition of these Iron-containing drugs, XRF studies showed 
that each Bhasma and even Shuddha Gairika are compound 
formations comprising of multiple trace elements. This explains the 
broad therapeutic activity of these drugs. With no dispute, these 
microelements must have entered into the end products as a result 
of the use of different types of medicinal plant material used in 
Shodhana and Marana procedures. Bhargava S. also confirms the 
presence of several trace elements in Loha Bhasma [21] Ashwini A et 
al. also confirm the multielemental nature of Ayurvedic bhasmas. 
However they braught brought to notice that Bhasma prepared by 
different pharmacies differ in their elemental composition which can 
be attributed to different preparation procedures adapted by them 
pharmacies [22]. 
During the entire procedure of Shodhana and Marana, a strong 
possibility of the formation of herbal ligands with metals is felt. Such 
a possibility presents a new vista of therapeutically effective herb-
metallic products. It is believed that the material adopts the 
therapeutic activity of the other material with which it is processed. 
Therefore, different plant materials are used in different Shodhana 
and Marana procedures. In this context, it is stated that, 
“Tad Tad Vyadhyupyuktanam aushdhanam jale Ayasah prakshepam 
prah”(A. P.3/246) 
This means, as per the therapeutic requirement, one can use a 
different medium for Shodhana and Marana procedures in different 
diseases. This suggests that different herbal media impose a 
different effect on metals and minerals while processing.  
The formation of different ligands from respective plants may be the 
reason for the difference in therapeutic activity of the drug product 
processed with it.  
CONCLUSION  
Pharmaceutical procedures such as Shodhana and Marana described 
in Ayurvedic classics, bring about a change in elemental composition 
and crystalline structure of the processed material. In the present 
study, such a change was studied and confirmed through XRD and 
XRF analysis. It is conclusively said that a change in the chemical 
constitution and crystalline structure is observed in the 
metal Loha (Iron) and iron-containing minerals Gairika (red 
ochre), Mandura (iron slag), Kasisa (green vitriol), and 
Suvarnamakshika (Copper pyrite) as a result of Shodhana and 
Marana. The basic iron element is transformed into its oxide. Apart 
from Iron oxide, the end product Bhasma is also observed to contain 
few trace elements like-K, Ca, P, AL, O, Ma, Zn. The presence of trace 
elements is deemed to be a result of the processing of the raw 
material with different types of plant materials.  
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